The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Interferon‐α/β–mediated innate immune mechanisms in dermatomyositis
Abstract
Dermatomyositis has been modeled as an autoimmune disease largely mediated by the adaptive immune system, including a local humorally mediated response with B and T helper cell muscle infiltration, antibody and complement‐mediated injury of capillaries, and perifascicular atrophy of muscle fibers caused by ischemia. To further understand the pathophysiology of dermatomyositis, we used microarrays, computational methods, immunohistochemistry and electron microscopy to study muscle specimens from 67 patients, 54 with inflammatory myopathies, 14 with dermatomyositis. In dermatomyositis, genes induced by interferon‐α/β were highly overexpressed, and immunohistochemistry for the interferon‐α/β inducible protein MxA showed dense staining of perifascicular, and, sometimes all myofibers in 8/14 patients and on capillaries in 13/14 patients. Of 36 patients with other inflammatory myopathies, 1 patient had faint MxA staining of myofibers and 3 of capillaries. Plasmacytoid dendritic cells, potent CD4+ cellular sources of interferon‐α, are present in substantial numbers in dermatomyositis and may account for most of the cells previously identified as T helper cells. In addition to an adaptive immune response, an innate immune response characterized by plasmacytoid dendritic cell infiltration and interferon‐α/β inducible gene and protein expression may be an important part of the pathogenesis of dermatomyositis, as it appears to be in systemic lupus erythematosus. Ann Neurol 2005;57:664–678
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Nature of the Principal Type 1 Interferon-Producing Cells in Human Blood
Siegal, F. P., Kadowaki, N., Shodell, M., Fitzgerald-Bocarsly, P. A., Shah, K., Ho, S., Antonenko, S., & Liu, Y.-J. (1999) · Science · doi:10.1126/science.284.5421.1835 · Cited by 2,293
Baechler, E. C., Batliwalla, F. M., Karypis, G., Gaffney, P. M., Ortmann, W. A., Espe, K. J., Shark, K. B., Grande, W. J., Hughes, K. M., Kapur, V., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0337679100 · Cited by 2,240
Interferon and Granulopoiesis Signatures in Systemic Lupus Erythematosus Blood
Bennett, L., Palucka, A. K., Arce, E., Cantrell, V., Borvak, J., Banchereau, J., & Pascual, V. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021553 · Cited by 1,958
Medzhitov, R., & Janeway, C. (2000) · New England Journal of Medicine · doi:10.1056/nejm200008033430506 · Cited by 1,825
Der, S. D., Zhou, A., Williams, B. R. G., & Silverman, R. H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15623 · Cited by 1,816
IMMUNOBIOLOGY : the immunesystem in health and disease
Janeway, C. A. (1994) · Cited by 1,757
Polymyositis and dermatomyositis
Dalakas, M. C., & Hohlfeld, R. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14368-1 · Cited by 1,416
Dzionek, A., Fuchs, A., Schmidt, P., Cremer, S., Zysk, M., Miltenyi, S., Buck, D. W., & Schmitz, J. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.11.6037 · Cited by 1,298
Polymyositis and Dermatomyositis
Hohlfeld, R., Hofmann, W. W., & Hanley, D. F. (1994) · Neurocritical Care · doi:10.1007/978-3-642-87602-8_72 · Cited by 1,083
Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures
Goodbourn, S., Didcock, L., & Randall, R. E. (2000) · Journal of General Virology · doi:10.1099/0022-1317-81-10-2341 · Cited by 977
Hoogendijk, J. E., Amato, A. A., Lecky, B. R., Choy, E. H., Lundberg, I. E., Rose, M. R., Vencovsky, J., de Visser, M., & Hughes, R. A. (2004) · Neuromuscular Disorders · doi:10.1016/j.nmd.2004.02.006 · Cited by 950
Self-citationInclusion body myositis and myopathies
Griggs, R. C., Askanas, V., DiMauro, S., Engel, A., Karpati, G., Mendell, J. R., & Rowland, L. P. (1995) · Annals of Neurology · doi:10.1002/ana.410380504 · Cited by 837
Farkas, L., Beiske, K., Lund-Johansen, F., Brandtzaeg, P., & Jahnsen, F. L. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61689-6 · Cited by 730
Arahata, K., & Engel, A. G. (1984) · Annals of Neurology · doi:10.1002/ana.410160206 · Cited by 630
Microvascular Deposition of Complement Membrane Attack Complex in Dermatomyositis
Kissel, J. T., Mendell, J. R., & Rammohan, K. W. (1986) · New England Journal of Medicine · doi:10.1056/nejm198602063140601 · Cited by 524
Bengtsson, A. A., Sturfelt, G., Truedsson, L., Blomberg, J., Alm, G., Vallin, H., & Rönnblom, L. (2000) · Lupus · doi:10.1191/096120300674499064 · Cited by 464
Interferon‐Induced Mx Proteins: Dynamin‐Like GTPases with Antiviral Activity
Haller, O., & Kochs, G. (2002) · Traffic · doi:10.1034/j.1600-0854.2002.31003.x · Cited by 460
O'Doherty, U., Steinman, R. M., Peng, M., Cameron, P. U., Gezelter, S., Kopeloff, I., Swiggard, W. J., Pope, M., & Bhardwaj, N. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.3.1067 · Cited by 383
Han, G.-M., Chen, S.-L., Shen, N., Ye, S., Bao, C.-D., & Gu, Y.-Y. (2003) · Genes & Immunity · doi:10.1038/sj.gene.6363966 · Cited by 264
Tezak, Z., Hoffman, E. P., Lutz, J. L., Fedczyna, T. O., Stephan, D., Bremer, E. G., Krasnoselska-Riz, I., Kumar, A., & Pachman, L. M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.8.4154 · Cited by 238
Molecular profiles of inflammatory myopathies
Greenberg, S. A., Sanoudou, D., Haslett, J. N., Kohane, I. S., Kunkel, L. M., Beggs, A. H., & Amato, A. A. (2002) · Neurology · doi:10.1212/wnl.59.8.1170 · Cited by 213
Self-citationIDIOPATHIC INFLAMMATORY MYOPATHIES
Amato, A. A., & Barohn, R. J. (1997) · Neurologic Clinics · doi:10.1016/s0733-8619(05)70337-6 · Cited by 190
Self-citationExperimental ischemic myopathy
Karpati, G., Carpenter, S., Melmed, C., & Eisen, A. A. (1974) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(74)90148-8 · Cited by 170
Human Lupus Inclusions and Interferon
Rich, S. A. (1981) · Science · doi:10.1126/science.6166984 · Cited by 161
Muscle pathology in dysferlin deficiency
Fanin, M., & Angelini, C. I. (2002) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.2002.00417.x · Cited by 156
Seidman, R. (2001) · Journal of Clinical Neuromuscular Disease · doi:10.1097/00131402-200112000-00014 · Cited by 152
Accola, M. A., Huang, B. Q., Masri, A. A., & McNiven, M. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201641200 · Cited by 138
αB-Crystallin immunolocalization yields new insights into inclusion body myositis
Banwell, B., & Engel, A. G. (2000) · Neurology · doi:10.1212/wnl.54.5.1033 · Cited by 133
The natural interferon-α producing cells in systemic lupus erythematosus
Rönnblom, L., & Alm, G. V. (2002) · Human Immunology · doi:10.1016/s0198-8859(02)00757-7 · Cited by 112
Interferon‐α: A new target for therapy in systemic lupus erythematosus?
Crow, M. K. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11226 · Cited by 86
Protein interaction for an interferon-inducible systemic lupus associated gene, IFIT1
Ye, S., Pang, H., Gu, Y.-Y., Hua, J., Chen, X.-G., Bao, C.-D., Wang, Y., Zhang, W., Qian, J., Tsao, B. P., et al. (2003) · British journal of rheumatology · doi:10.1093/rheumatology/keg315 · Cited by 79
Magnusson, M., Magnusson, S., Vallin, H., Rönnblom, L., & Alm, G. V. (2001) · Scandinavian Journal of Immunology · doi:10.1046/j.1365-3083.2001.01018.x · Cited by 74
Immune effector mechanisms in inflammatory myopathies.
Engel, A. G., Arahata, K., & Emslie‐Smith, A. M. (1990) · PubMed · Cited by 65
Illa, I., Gallardo, E., Gimeno, R., Serrano, C., Ferrer, I., & Juárez, C. (1997) · Europe PMC (PubMed Central) · Cited by 60
Directing Autoimmunity to Nucleoprotein Particles
Hardin, J. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030130 · Cited by 39
Cited by
Type I Interferon in Systemic Lupus Erythematosus and Other Autoimmune Diseases
Banchereau, J., & Pascual, V. (2006) · Immunity · doi:10.1016/j.immuni.2006.08.010 · Cited by 963
International MS Genetics Consortium, De Jager, P. L., Jia, X., Wang, J., de Bakker, P. I. W., Ottoboni, L., Aggarwal, N. T., Piccio, L., Raychaudhuri, S., Tran, D., et al. (2009) · Nature Genetics · doi:10.1038/ng.401 · Cited by 800
Dalakas, M. C. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1402225 · Cited by 790
Idiopathic inflammatory myopathies
Lundberg, I. E., Fujimoto, M., Vencovsky, J., Aggarwal, R., Holmqvist, M., Christopher-Stine, L., Mammen, A. L., & Miller, F. W. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00321-x · Cited by 703
Discovering statistically significant pathways in expression profiling studies
Tian, L., Greenberg, S. A., Kong, S. W., Altschuler, J., Kohane, I. S., & Park, P. J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506577102 · Cited by 648
Self-citation
Metadata
- Authors
- Greenberg, S. A., Pinkus, J. L., Pinkus, G. S., Burleson, T., Sanoudou, D., Tawil, R., Barohn, R. J., Saperstein, D. S., Briemberg, H. R., Ericsson, M., Park, P., & Amato, A. A.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2005-04-25
- Volume
- 57
- Issue
- 5
- Pages
- 664-678
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2072328028
- Cited by
- 621
- References
- 35
- FWCI
- 20.94
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.